STOCK TITAN

Braidwell group discloses 5.5% Surrozen (SRZN) ownership stake

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Braidwell and affiliates disclosed a significant position in Surrozen, Inc. common stock. As of December 31, 2025, Braidwell LP, Braidwell Management LLC, Alexander T. Karnal, and Brian J. Kreiter may be deemed beneficial owners of 470,000 shares, representing about 5.5% of Surrozen’s outstanding common stock.

All 470,000 shares are directly owned by Braidwell Partners Master Fund LP, with each reporting person sharing voting and dispositive power and no sole authority. The stake is reported as being held in the ordinary course of business and not for the purpose of changing or influencing control of Surrozen.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BRAIDWELL LP
Signature:/s/ COLIN BETTISON
Name/Title:COLLIN BETTISON / AUTHORIZED SIGNATORY
Date:02/17/2026
BRAIDWELL MANAGEMENT LLC
Signature:/s/ COLIN BETTISON
Name/Title:COLLIN BETTISON / AUTHORIZED SIGNATORY
Date:02/17/2026
ALEXANDER T. KARNAL
Signature:/s/ ALEXANDER T. KARNAL
Name/Title:ALEXANDER T. KARNAL
Date:02/17/2026
BRIAN J. KREITER
Signature:/s/ BRIAN J. KREITER
Name/Title:BRIAN J. KREITER
Date:02/17/2026
Exhibit Information

Exhibit 1: Joint Filing Agreement, dated February 17, 2026

FAQ

What stake in Surrozen (SRZN) did Braidwell report?

Braidwell and affiliated reporting persons disclosed beneficial ownership of 470,000 Surrozen common shares. This position represents approximately 5.5% of Surrozen’s outstanding common stock as of December 31, 2025, based on 8,571,421 shares outstanding reported in the company’s Form 10-Q.

Who are the reporting persons in this Surrozen (SRZN) Schedule 13G?

The filing lists Braidwell LP, Braidwell Management LLC, Alexander T. Karnal, and Brian J. Kreiter as joint reporting persons. They report shared voting and dispositive power over the same 470,000 Surrozen shares, all held through Braidwell Partners Master Fund LP.

How much of Surrozen’s (SRZN) stock does the 470,000-share position represent?

The 470,000 Surrozen common shares represent approximately 5.5% of the outstanding class. This percentage is calculated using 8,571,421 shares outstanding as of November 5, 2025, as disclosed in Surrozen’s Form 10-Q for the quarter ended September 30, 2025.

Do the Braidwell reporting persons control Surrozen (SRZN)?

The filing states the Surrozen shares were acquired and are held in the ordinary course of business. It specifically certifies they were not acquired and are not held for the purpose of changing or influencing control of Surrozen or in connection with any such transaction.

Who has voting and dispositive power over the Surrozen (SRZN) shares reported?

Each reporting person reports 0 shares with sole voting or dispositive power and 470,000 shares with shared voting and dispositive power. All reported shares are directly owned by Braidwell Partners Master Fund LP, over which the reporting persons share authority.

What class of Surrozen (SRZN) securities is covered in this ownership filing?

The filing covers Surrozen, Inc. common stock with a par value of $0.0001 per share. The securities are identified by CUSIP 86889P208, and the reported ownership relates solely to this class of equity securities.
Surrozen Inc

NASDAQ:SRZN

SRZN Rankings

SRZN Latest News

SRZN Latest SEC Filings

SRZN Stock Data

215.06M
8.21M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SOUTH SAN FRANCISCO